ORMP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Oramed Pharmaceuticals Inc (ORMP) is not a strong buy for a beginner, long-term investor at this moment. While the technical indicators show a bullish trend, the overbought RSI and lack of significant positive catalysts, combined with poor financial performance and no recent AI or SwingMax trading signals, suggest holding off on investment for now.
The MACD is positive and expanding (0.0455), indicating bullish momentum. The RSI is at 85.924, signaling overbought conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key resistance levels are R1: 3.842 and R2: 3.984, while support levels are S1: 3.381 and S2: 3.238.
Bullish technical indicators (MACD, moving averages).
Overbought RSI, poor financial performance (net income and EPS significantly down YoY), no recent news, no significant hedge fund or insider trading trends, and no recent congress trading data.
In 2025/Q4, revenue remained at 0 with no growth. Net income dropped significantly (-198.23% YoY) to 10,009,000, and EPS fell by -196.00% YoY to 0.24. Gross margin remained flat at 0.65.
No recent analyst ratings or price target changes available.
